Alessandro Armuzzi

机构：Università Cattolica del Sacro Cuore, Humanitas University, IRCCS Humanitas Research Hospital · ORCID：0000-0003-1572-0118

发表论文 989 篇 · 总被引 26257 次 · h-index 72

代表论文

• Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study (2026 · The American Journal of Gastroenterology · 被引 4)
• Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-Line Therapy in Anti-Tumor Necrosis Factor-Experienced Patients With Ulcerative Colitis (2026 · Clinical Gastroenterology and Hepatology · 被引 3)
• Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality? (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 2)
• Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care (2026 · Autoimmunity Reviews · 被引 2)
• Real‐World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases ( IG ‐ IBD ) (2026 · Alimentary Pharmacology & Therapeutics · 被引 1)
• Sustainable monitoring in inflammatory bowel disease: comparative carbon, energy, waste, and cost impact of intestinal ultrasound versus colonoscopy (2026 · Digestive and Liver Disease · 被引 1)